Surmodics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Surmodics generated cash of $248,000, which is less than the previous year. Cash used in financing activities reached the amount of -$2,950,000 last year. Net change in cash is therefore -$5,304,000.
Cash Flow
| 2015 | 15.02M | 16.69M | -19.63M |
|---|---|---|---|
| 2016 | 25.16M | -55.46M | -199K |
| 2017 | 14.05M | -16.18M | -6.51M |
| 2018 | 34.05M | -23.5M | -3.39M |
| 2019 | 8.03M | 9.75M | -11.02M |
| 2020 | 14.01M | -9.06M | -4.64M |
| 2021 | 15.38M | -25.23M | 10.22M |
| 2022 | -17.22M | 6.23M | -375K |
| 2023 | 10.51M | -6.82M | 18.40M |
| 2024 | 248K | -2.93M | -2.95M |
SRDX Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 41.41M | 18.99M | 31.15M | 30.78M | 30.36M | 23.66M | 16.53M | 24.98M | 55.58M | 43.51M |
Operating activities | ||||||||||
Net income | -11.54M | -1.53M | -27.27M | 4.23M | 1.12M | 7.59M | -4.45M | 3.92M | 9.98M | 13.44M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 8.69M | 8.52M | 9.14M | 8.01M | 7.26M | 7.31M | 6.43M | 5.55M | 4.87M | 2.80M |
Stock-based compensation expense | 8.21M | 7.60M | 7.05M | 5.86M | 5.45M | 5.07M | 0 | 3.47M | 3.84M | 2.38M |
| Deferred income tax benefit | 8.21M | 7.60M | 7.05M | 5.86M | 5.45M | 5.07M | 0 | 3.47M | 3.84M | 2.38M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -5.23M | -977K | -1.52M | -3.46M | 3.46M | -1.63M | -1.77M | -528K | 911K | -2.72M |
Inventories | -328K | -3.02M | -5.06M | -818K | -1.37M | -543K | -513K | 97K | -143K | -162K |
Accounts payable | -232K | -183K | 1.60M | 264K | -483K | -765K | 5.24M | 368K | 3.71M | 373K |
Cash generated by operating activities | 248K | 10.51M | -17.22M | 15.38M | 14.01M | 8.03M | 34.05M | 14.05M | 25.16M | 15.02M |
Investing activities | ||||||||||
Purchases Of Investments | -25.44M | -3.90M | 0 | -22.72M | -59.91M | -44.97M | -81.53M | -73.67M | -24.51M | -3.37M |
Investments In Property Plant And Equipment | -3.49M | -2.91M | -3.37M | -6.27M | -3.67M | -6.74M | -14.09M | -6.43M | -8.19M | -1.87M |
Acquisitions Net | 0 | 0 | 0 | -39.55M | 9.06M | 750K | 5M | 0 | -25.85M | -270K |
Cash generated by investing activities | -2.93M | -6.82M | 6.23M | -25.23M | -9.06M | 9.75M | -23.5M | -16.18M | -55.46M | 16.69M |
Financing activities | ||||||||||
Common Stock Issued | 1.21M | 1.25M | 1.24M | 3.12M | 1.61M | 723K | 2.08M | 444K | 494K | 710K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -2.75M | -2.53M | 0 | -4.55M | -6.85M | -388K | -20.82M |
Repayments of term debt | 0 | 19.66M | 0 | -10M | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -2.95M | 18.40M | -375K | 10.22M | -4.64M | -11.02M | -3.39M | -6.51M | -199K | -19.63M |
Net Change In Cash | -5.30M | 22.42M | -12.15M | 368K | 424K | 6.69M | 7.13M | -8.45M | -30.60M | 12.07M |
Cash at end of period | 36.11M | 41.41M | 18.99M | 31.15M | 30.78M | 30.36M | 23.66M | 16.53M | 24.98M | 55.58M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |